Integrative Early Breastfeeding Support in NICU
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Mar 17, 2022
Trial Information
Current as of August 11, 2025
Unknown status
Keywords
ClinConnect Summary
Preterm infants are suffered from preterm-related medical sequelae and neurobehavioral problems, which required interdisciplinary intervention. Breast milk is the best nutrition for preterm infants. However, consistent breastfeeding is quite challenging to most mothers of prematurity. The purpose of this study is to investigate the effect of integrative early breastfeeding support and intervention programs on preterm infants' breastfeeding rate, neurobehavioral development, and maternal mental health. Method: The prospective, single-blinded randomized controlled trial would be conducted in ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • the mother of preterm baby whose gestational age is between 28 weeks and 34 6/7 weeks.
- Exclusion Criteria:
- • mother less than 20-years-old
- • not intend to breastfeed
- • baby's vital sign is not stable the need frequent medical intervention
- • baby had congenital anomaly, gene anomaly, neurological disease, mitochondrial disease or metabolic diseases
- • mother or baby receive major surgery
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Pei-Yu Yang, MSc
Study Director
National Taiwan University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials